미국의 액체생검 시장
Liquid Biopsy | Medtech 360 | Market Insights | United States
상품코드 : 933299
리서치사 : Decision Resources Group - Medtech
발행일 : 2020년 03월
페이지 정보 : 영문

한글목차

미국의 액체생검은 미국의 고령 인구, 가치 기반 의료로의 이동, 비침습성, 저비용 등에 의해 2028년까지 급속한 성장을 이룰 것으로 예측됩니다.

미국의 액체생검(Liquid Biopsy) 시장에 대해 조사 분석했으며, 종합적인 데이터 등, 시장 현황, 10년간 예측에 대한 체계적인 정보를 제공합니다.

목차

미국

요약

주요 요약

갱신 이력

액체생검 시장

스크리닝 검사 시장

치료 선택 검사 시장

모니터링 검사 시장

부록

KSM 20.05.07
영문 목차

영문목차

The US market for liquid biopsy tests will exhibit rapid growth through 2028, driven by the aging US population, the shift toward value-based health care, the noninvasive nature of liquid biopsy tests, and the low cost of administration of liquid biopsies relative to tissue-based biopsy testing. These factors will fuel strong uptake of newer tests with improved diagnostic accuracy and reduced turnaround time.

This Medtech 360 Report provides comprehensive data and analysis on the current state of the market for liquid biopsies in the US across a 10-year period.

The use of liquid biopsy tests will expand rapidly over the forecast period.

Expansion in CMS reimbursement coverage of liquid biopsy testing, changes in section D Medicare reimbursement, and the continued rollout of Medicare value-based programs will drive liquid biopsy testing.

Advancements in liquid biopsy technology-particularly the types of substrates chosen to be isolated and analyzed-continue to drive innovation in the market and differentiate new entrants.

Given the nascent nature of the liquid biopsy market, the pace of market expansion going forward will be contingent upon regulatory approvals, consistent research and development funding, and the emergence of favorable clinical data.

Table of Contents

United States

Abstract

Executive Summary

Key Report Updates

Liquid Biopsy Market

Screening Test Market

Therapy Selection Test Market

Appendix

(주)글로벌인포메이션 02-2025-2992 koreainfo@gii.co.jp
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기